Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vision Sciences was a medical device company specializing in the design, development, and manufacture of flexible endoscopic products for the urology, pulmonology, gastroenterology, and ENT markets. The company's core innovation was the EndoSheath technology, a sterile, disposable microbial barrier that fits over a flexible endoscope, allowing for rapid turnaround times and reduced risk of cross-contamination. This system eliminated the need for time-consuming high-level disinfection between procedures, significantly enhancing clinical workflow and patient safety. In 2015, Vision Sciences merged with Uroplasty to form Cogentix Medical, which was later acquired by Laborie Medical Technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vision Sciences.